Neurocrine-Takeda antidepressant hits main mark in phase 2 trial - Fierce Biotech

Submitted by Anonymous (not verified) on Tue, 04/23/2024 - 14:44

Neurocrine-Takeda antidepressant hits main mark in phase 2 trial  Fierce Biotech